Vertical: CNMBase Year: 2025
Market Size (2025)
$40.26M
Projected (2032)
$54.24M
CAGR (2022–2032)
4.4%
Key Players
9+
Market Overview
The global medium chain fatty acids (MCFA) feed market was valued at USD 40.258 million in 2025 and is projected to reach USD 54.238 million by 2032, registering a CAGR of 4.35% over 2026–2032. The market expanded from USD 35.420 million in 2022 to USD 38.577 million in 2024, and is expected to add USD 13.980 million in absolute value between 2025 and 2032.
Medium chain fatty acids (caprylic C8, capric C10 and lauric C12 acids, supplied as free acids, salts, and mono-, di- and triglycerides) are used in compound feed, premixes and drinking water for their antimicrobial activity against bacterial and enveloped viral pathogens, their role in supporting gut integrity, and their value as a rapidly absorbed energy source for young animals. Demand is anchored in three structural developments: the withdrawal of antibiotic growth promoters across major producing countries, the spread of African swine fever (ASF) and other transboundary diseases that have placed feed biosecurity on the agenda of integrators and feed mills, and continued growth in global compound feed output, which Alltech's 2026 Agri-Food Outlook places at approximately 1.44 billion tonnes in 2025.
The market remains a specialised niche within the broader feed acidifier and gut-health additive space. Value growth is supported by the gradual replacement of formaldehyde-based feed mitigants, the shift from single-acid products to blended and glyceride forms with targeted release, and the expansion of intensive poultry and swine production in Asia Pacific, Latin America and the Middle East & Africa.
Key Findings
By product type: Caprylic & Capric Acids is the largest segment, accounting for 55.0% of the market in 2025 (USD 22.142 million), and also the fastest-growing segment, with a CAGR of 4.89% over 2026–2032, compared with 3.66% for Lauric Acid.
By livestock: Swine is the largest segment with a 50.0% share in 2025 (USD 20.129 million), while Others is the fastest-growing segment at a CAGR of 5.15%. Poultry follows with a CAGR of 4.66%.
By region: Asia Pacific is the leading region with USD 12.883 million in 2025 (32.0% share). Middle East & Africa is the fastest-growing region at a CAGR of 5.67%, followed by Asia Pacific at 5.35%.
By country: The U.S. is the leading country market, valued at USD 6.377 million in 2025, followed by China at USD 5.797 million. India is the fastest-growing country, with a CAGR of 9.89% over 2026–2032.
Growth outlook: The market is projected to grow from USD 42.012 million in 2026 to USD 54.238 million in 2032, with emerging regions gaining share from Europe and North America, whose CAGRs (3.33% and 3.45%) are below the global average.
Segmentation Summary
The market is analysed by product type (Caprylic & Capric Acids and Lauric Acid), by livestock (Swine, Poultry and Others) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis for 20 country and sub-regional markets. Caprylic & Capric Acids lead on account of their stronger documented activity against enveloped viruses and Gram-negative bacteria and their use in feed mitigation programmes, whereas Lauric Acid, frequently supplied as glycerol monolaurate, is more widely used in poultry for Gram-positive pathogen control. Swine is the core application, reflecting the role of MCFA in piglet weaning diets and in feed biosecurity against porcine epidemic diarrhoea virus (PEDV) and ASF.
Competitive Landscape Summary
The market is moderately fragmented. It combines diversified animal nutrition and specialty chemical groups that offer MCFA within broader gut-health portfolios (Adisseo, through its FRAmelco business; Nutreco, through Trouw Nutrition and Selko; BASF; Eastman; and Kemin Industries) with specialist suppliers of MCFA blends and functional lipids (Nuscience, part of Royal Agrifirm Group; Berg + Schmidt; and PMI Nutritional Additives of Land O'Lakes) and oleochemical producers that supply medium chain triglycerides and glycerol monolaurate to premixers (Oleon, part of Avril Group). Competition is based on formulation know-how, proprietary blends and patents, trial data on pathogen reduction and performance, technical service to feed mills, and regulatory registrations. Since 2022, activity has centred on portfolio acquisitions, regional expansion into the Middle East and Africa, and launches of new delivery formats such as water-soluble monoglycerides.
Challenges and Opportunities
The principal challenges are the price volatility of lauric oils (coconut and palm kernel oil), which are the main feedstocks for C8, C10 and C12 acids; the cost premium of MCFA products relative to conventional organic acids and formaldehyde-based mitigants; the strong odour and handling difficulties of free acids; and the absence of a harmonised regulatory category for MCFA as gut-health or pathogen-control agents, which restricts the claims suppliers can make in several jurisdictions. Opportunities arise from tighter restrictions on antimicrobial use, the continued spread of ASF into new territories, the growth of poultry production in South and Southeast Asia, the Middle East and Latin America, and the development of encapsulated, glyceride and non-palm (fermentation-derived) MCFA sources that improve palatability, targeted release and sustainability credentials.
Future Outlook
Over 2026–2032 the market is expected to grow at a CAGR of 4.35%, reaching USD 54.238 million. Caprylic & Capric Acids are projected to increase their share as feed mitigation and biosecurity applications expand, reaching USD 30.900 million by 2032. Asia Pacific is projected to add USD 5.640 million between 2025 and 2032, the largest absolute gain of any region, driven by China and India, while Latin America and Middle East & Africa will grow faster than the global average on the back of export-oriented poultry and pork production. Mature markets in Europe and North America will grow more slowly but remain important for product development, regulatory precedent and premium blended formulations.
The Medium Chain Fatty Acids Feed Market market is projected to grow at a CAGR of 4.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Medium chain fatty acids are saturated fatty acids with an aliphatic tail of six to twelve carbon atoms. In animal nutrition, the commercially relevant MCFA are caprylic acid (octanoic acid, C8:0), capric acid (decanoic acid, C10:0) and lauric acid (dodecanoic acid, C12:0). They are derived mainly from the fractionation of lauric oils: coconut oil and palm kernel oil each contain more than 45% lauric acid, with coconut oil containing approximately 5.1% C8 and 5.2% C10 and palm kernel oil approximately 2.5% C8 and 2.9% C10. Owing to their amphipathic structure, MCFA disrupt the lipid membranes of bacteria and enveloped viruses, and in the animal they are absorbed directly via the portal vein and oxidised rapidly, providing a readily available energy source.
For the purpose of this study, the MCFA feed market covers MCFA-based products used in the feed and drinking water of livestock, and is valued at the level of the MCFA product sold to feed manufacturers, premixers, integrators and farms.
Included:
Caprylic and capric acids (C8 and C10) and lauric acid (C12) supplied as free fatty acids, salts, mono-, di- and triglycerides (including glycerol monolaurate and medium chain triglycerides), and MCFA-based blends in which MCFA are the principal active component.
Products used in compound feed, premixes, supplements, milk replacers and drinking water for swine, poultry and other livestock, including ruminants and aquaculture species.
Applications for gut health and performance, feed hygiene and feed pathogen mitigation, and energy supply for young animals.
Excluded:
Short chain fatty acids (such as formic, propionic and butyric acids and their derivatives) and long chain fatty acids, and multi-component acidifier blends in which MCFA are not the principal active component.
MCFA and lauric oils used in human food, dietary supplements, pharmaceuticals, cosmetics, personal care and industrial oleochemical applications.
Crude coconut oil and palm kernel oil used as generic dietary fat sources in feed.
Scope of the Study
The scope of the study is as follows:
By Product Type: Caprylic & Capric Acids; Lauric Acid.
By Livestock: Swine; Poultry; Others.
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: Historic years 2022, 2023 and 2024; base year 2025; forecast years 2026–2032; CAGR period 2026–2032.
Currency/unit: All values are presented in USD Million.
Research Objectives
To estimate the size of the global MCFA feed market in 2022–2025 and forecast it for 2026–2032 in value terms (USD Million).
To analyse the market by product type (Caprylic & Capric Acids and Lauric Acid) and quantify the shift between C8/C10 and C12 products.
To assess demand from swine, poultry and other livestock, including the role of MCFA in weaning diets, broiler gut health and feed biosecurity.
To evaluate the market across five regions and 20 country and sub-regional markets, and to identify the regions and countries with the highest growth potential.
To examine the impact of antibiotic growth promoter bans, antimicrobial stewardship rules and transboundary animal diseases such as ASF and PEDV on MCFA adoption.
To assess the influence of lauric oil feedstock supply and prices on product costs and supply security.
To profile the competitive environment, including the positioning of key suppliers and strategic developments since 2022.
To identify the regulatory frameworks governing MCFA use in feed in major regions and their implications for product registration and claims.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research and analytical modelling. The process began with defining the market and its segmentation, followed by the collection of data on livestock populations, compound feed production, additive inclusion practices, product prices and company activity. Preliminary market estimates were developed using top-down and bottom-up approaches, validated through discussions with industry participants, and triangulated to arrive at final estimates for the historic years and the base year. The forecast was then developed by analysing the drivers, restraints and trends expected to shape the market over 2026–2032.
Stage 1 – Scoping: definition of the MCFA product scope, livestock categories, regions and countries, and timeline.
Stage 2 – Data collection: secondary research on feed production, livestock inventories, regulation and company activity; primary research with suppliers, feed producers and end users.
Stage 3 – Market estimation: construction of top-down and bottom-up models and reconciliation of results.
Stage 4 – Validation: data triangulation and review of estimates with industry participants.
Stage 5 – Forecasting and analysis: projection of segment, regional and country values and preparation of qualitative analysis.
Secondary Research
Secondary research was used to build an understanding of the market structure, collect quantitative inputs for the market models and identify the key participants. The principal source categories were:
Industry associations: publications of the International Feed Industry Federation, FEFAC (European Feed Manufacturers' Federation), FEFANA (EU Association of Specialty Feed Ingredients and their Mixtures), the American Feed Industry Association, the Brazilian Feed Industry Association (Sindirações) and national pork and poultry producer organisations.
Government and intergovernmental bodies: FAO, WOAH, OECD-FAO Agricultural Outlook, USDA, US FDA Center for Veterinary Medicine, the European Commission and EFSA, China's Ministry of Agriculture and Rural Affairs, India's Department of Animal Husbandry and Dairying, Brazil's MAPA, Japan's MAFF and FAMIC, and the Canadian Food Inspection Agency.
Regulatory documents: feed additive regulations and registers, antimicrobial use reports such as the EU ESVAC series and the FDA annual summary of antimicrobial sales, and ASF situation reports.
Company filings: annual reports, investor presentations, press releases and product literature of feed additive, animal nutrition and oleochemical companies.
Trade journals and scientific literature: feed industry publications and peer-reviewed studies on MCFA efficacy against pathogens such as PEDV, ASF virus, Salmonella and Clostridium perfringens, and on performance in piglets and broilers.
Paid databases: trade statistics, company financial databases and commodity price series for coconut oil, palm kernel oil and oleochemicals.
Primary Research
Primary research was conducted to validate the secondary findings, fill data gaps and obtain qualitative insight into market dynamics. Interviews were held with participants across the value chain on both the supply and demand sides.
Supply side: product managers, technical directors and regional sales managers of MCFA and feed additive suppliers; oleochemical producers; distributors of feed additives.
Demand side: nutritionists and procurement managers at compound feed manufacturers and premixers; integrated swine and poultry producers; veterinarians and animal health consultants.
Objectives: to validate market size and segment splits; understand inclusion rates, pricing and product formats; assess adoption trends by species and region; and gauge the impact of regulation, disease pressure and feedstock prices on demand.
Market Size Estimation
Top-down approach: The global feed additives and acidifier markets were used as the starting point. The share attributable to MCFA products was estimated using supplier information, product portfolios and expert inputs, and then allocated across product types, livestock categories and regions based on feed production volumes and adoption rates.
Bottom-up approach: Compound feed production by species and country was combined with estimated MCFA penetration rates (share of feed treated) and average inclusion rates to derive MCFA consumption volumes. Volumes were multiplied by average selling prices for each product type and region to arrive at market values, which were aggregated to regional and global totals.
Data triangulation: Results from the two approaches were compared and reconciled. Where differences arose, assumptions were reviewed against supplier information, trade data and primary interviews, and the final estimates were adjusted to achieve consistency across segments, regions and countries.
Forecasting Methodology
Forecasts were developed for each country and segment and aggregated to regional and global levels. The following factors were considered:
Projected growth of compound feed production and livestock inventories by species and country.
Regulatory developments on antibiotic growth promoters, medicated feed and veterinary antimicrobial use.
Incidence and spread of ASF, PEDV, avian influenza and other diseases relevant to feed biosecurity.
Trends in MCFA penetration and inclusion rates, product innovation and product mix.
Feedstock availability and price trends for coconut oil and palm kernel oil, and average selling price trends.
Macroeconomic indicators including GDP growth, population growth, meat consumption and trade.
The forecast combined trend analysis of historic data with driver-based adjustments reflecting expected changes in these factors. CAGR values were calculated for the 2026–2032 period.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024.
Base year: 2025.
Forecast period: 2026–2032.
Currency: USD Million. Values in local currency were converted at average annual exchange rates for the respective years, and forecast years assume constant exchange rates at 2025 levels.
Assumptions and Limitations
The regulatory environment for feed additives in major markets is assumed to remain broadly stable, with no outright prohibition of MCFA products in any covered country.
Feedstock prices for lauric oils are assumed to normalise from their 2025 highs without a prolonged supply disruption.
Disease outbreaks, including ASF, are assumed to follow recent patterns without an exceptional global shock to pig or poultry inventories.
Product prices are assumed to change in line with feedstock costs and product mix, without a structural price collapse.
Company-level sales of MCFA products are generally not reported separately; estimates for these are therefore based on modelled values and industry inputs.
Country markets grouped under "Rest of" categories are estimated in aggregate and are not analysed individually.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global MCFA feed market is moderately fragmented. No single supplier dominates, and the market includes three main groups of participants: diversified animal nutrition and specialty chemical companies that offer MCFA products as part of broad gut-health and feed hygiene portfolios; specialist suppliers whose portfolios are built around MCFA blends, monoglycerides and functional lipids; and oleochemical producers that supply medium chain triglycerides, monoglycerides and fatty acids to feed additive formulators and premixers. Regional formulators and distributors also play an important role in Asia Pacific, Latin America and the Middle East & Africa.
Competition is based on proprietary formulations and patents, the strength of efficacy data from research institutions and field trials, technical service to feed mills and integrators, regulatory registrations, and price. Leading suppliers increasingly position MCFA within integrated programmes combining organic acids, butyrates, phytogenics and other additives, and differentiate through delivery technologies such as glycerides, encapsulation and water-soluble formulations. Since 2022, strategic activity has focused on portfolio acquisitions, the reorganisation of feed additive businesses, expansion into the Middle East and Africa, and the development of non-palm fatty acid sources.
Key Player Positioning
Based on the breadth of their MCFA portfolios, geographic reach and technical capabilities, the key players can be grouped as follows:
Leaders: Adisseo (through FRAmelco), Nutreco (Trouw Nutrition and Selko) and Royal Agrifirm Group (through Nuscience). These companies have well-established MCFA and MCFA-glyceride product lines, global distribution and long experience in gut-health solutions. FRAmelco and Nuscience were among the pioneers of MCFA and glyceride products for feed, and Nutreco integrates MCFA into its multi-component Presan and Fysal ranges.
Challengers: Kemin Industries, BASF and Eastman. These companies have strong global presence, research capabilities and established feed additive businesses, with dedicated MCFA products such as Kemin's CaptiSURE feed biosecurity product, BASF's BalanGut LS monoglycerides and Eastman's Entero-Nova range of short and medium chain glycerides.
Niche players: Oleon (Avril Group), Berg + Schmidt and PMI Nutritional Additives (Land O'Lakes). These companies focus on specific product types, applications or regions, including medium chain triglycerides and glycerol monolaurate (Oleon), functional lipids and drinking water monoglycerides (Berg + Schmidt), and MCFA-based swine products for the US market (PMI).
Competitor Dashboard
The competitor dashboard rates each key player on product portfolio, regional presence, strategic alliances and industry experience in the MCFA feed market.
Threat of New Entrants: Medium
Access to fatty acid feedstock is relatively open, and MCFA blending does not require large capital investment.
Established suppliers hold patents, proprietary blends and extensive trial data, and have long-standing relationships with feed producers.
Regulatory registration requirements in several markets and the need for technical service capabilities raise barriers for new suppliers.
Bargaining Power of Suppliers: Medium
C8, C10 and C12 feedstocks are produced by a limited number of oleochemical producers concentrated in Southeast Asia.
C8 and C10 are minor fractions of lauric oils, so their availability depends on overall oleochemical output.
Integration of some additive producers into oleochemicals and the emergence of fermentation-based sources partially offset supplier power.
Bargaining Power of Buyers: High
Large feed manufacturers and integrators purchase significant volumes and negotiate on price and performance guarantees.
Buyers can switch to alternative gut-health additives or acidifiers.
Tight livestock production margins make buyers sensitive to the cost per tonne of treated feed.
Threat of Substitutes: High
Organic acids, butyrates, phytogenics, probiotics, prebiotics and enzymes compete for the same gut-health budgets.
Formaldehyde-based products compete in feed mitigation where they are permitted.
MCFA differentiate through antiviral activity and energy value, but substitutes are widely available.
Intensity of Competitive Rivalry: High
Multinational animal nutrition companies, specialty chemical groups, specialist suppliers and regional formulators compete in the market.
Competition centres on formulation, efficacy data, technical service and price.
Product differentiation is moderate, as many products use similar fatty acid profiles.
Threat of new entrants: Medium; Low capital needs offset by patents, trial data and registrations.
Bargaining power of suppliers: Medium; Concentrated oleochemical supply; C8/C10 are minor fractions.
Bargaining power of buyers: High; Large feed producers and integrators; availability of alternatives.
Threat of substitutes: High; Wide range of gut-health and feed hygiene additives.
Competitive rivalry: High; Many suppliers with similar fatty acid profiles.
Market estimates by geography (2032)
InsightAsia Pacific leads with $18.52M by 2032, while Middle East & Africa is projected to grow fastest at a 5.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $7.96M | $9.51M | $11.25M | 3.5% | 21% |
| Europe | $10.16M | $12.09M | $14.21M | 3.4% | 26% |
| Asia Pacific | $11.05M | $14.26M | $18.52M | 5.3% | 34% |
| Latin America | $4.55M | $5.75M | $7.29M | 4.8% | 13% |
| Middle East & Africa | $1.71M | $2.24M | $2.95M | 5.6% | 5% |
| Total | $35.42M | $43.84M | $54.24M | 4.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$54.24M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Caprylic & Capric Acids | $30.90M | 4.9% | 57% |
| Lauric Acid | $23.34M | 3.7% | 43% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Medium Chain Fatty Acids Feed Market covering market dynamics, competitive landscape, and strategic outlook.
The Medium Chain Fatty Acids Feed Market market is projected to reach $54.24M by 2032, growing at 4.4% CAGR. The Caprylic & Capric Acids segment holds the largest share.
The MCFA feed market is shaped by regulatory pressure on antimicrobial use, disease risk in swine and poultry production, the economics of livestock production and the supply of lauric oil feedstocks. This chapter assesses the macro and micro factors influencing the market, followed by its drivers, restraints, opportunities, and key trends and challenges. The impact scores in the growth factor analysis are analyst assessments on a scale of 1 to 10, where a higher score indicates a stronger influence on the market in the period concerned.
Restrictions on Antibiotic Growth Promoters and Antimicrobial Use
Regulatory restrictions on antibiotics in feed are the most important structural driver of MCFA demand. The European Union prohibited antibiotics as growth promoters from 1 January 2006 under Regulation (EC) No 1831/2003, and Regulations (EU) 2019/4 on medicated feed and (EU) 2019/6 on veterinary medicinal products, applicable since 28 January 2022, prohibit the prophylactic use of antimicrobial medicated feed. In the United States, Guidance for Industry #213 removed growth-promotion claims for medically important antimicrobials in January 2017 and moved their in-feed use under the Veterinary Feed Directive, while Guidance #263 moved the remaining over-the-counter products to prescription status in June 2023. China withdrew all growth-promoting drug feed additives other than traditional Chinese medicines from 2020 under MARA Announcement No. 194, and India prohibited colistin in food-producing animals and feed supplements in 2019. These measures have shifted producers towards non-antibiotic tools for gut health and pathogen control. MCFA, with documented activity against Gram-positive bacteria, Gram-negative bacteria in blended form, and enveloped viruses, have become one of the established options alongside organic acids, butyrates, phytogenics and probiotics.
Feed Biosecurity against ASF, PEDV and Other Pathogens
The identification of feed and feed ingredients as a route for the transmission of viral pathogens has created demand for feed mitigants. Research at Kansas State University and related groups showed that MCFA blends of C6, C8 and C10 reduced PEDV in feed ingredients and that a 1% MCFA blend was among the strongest inhibitors tested, and a 2020 study published in Transboundary and Emerging Diseases reported that an MCFA-based liquid additive reduced ASF virus infectivity in a dose-dependent manner. ASF has continued to spread: according to WOAH, 71 countries and territories reported outbreaks between January 2022 and October 2025, with more than 2.28 million domestic pig losses, and the disease was confirmed in Taiwan in October 2025 and in wild boar in Spain in November 2025, the first case there since 1994. These developments reinforce the use of MCFA-based mitigants in feed mills and on farms, particularly by integrators exposed to export market restrictions.
Growth in Compound Feed Production and Intensive Livestock Farming
Global compound feed production continues to expand as meat consumption rises and production shifts from backyard to commercial systems that rely on formulated feed. Alltech's 2026 Agri-Food Outlook estimates global feed production at approximately 1.44 billion tonnes in 2025, up 2.9%, including 380.9 million tonnes of pig feed and 400.4 million tonnes of broiler feed, with China (330.1 million tonnes), the United States (267.4 million tonnes), Brazil (89.9 million tonnes) and India (57.7 million tonnes) as the largest producers. The OECD-FAO Agricultural Outlook 2026–2035 projects poultry meat to account for the largest share of growth in global meat consumption. As commercial operations expand in Asia, Latin America and the Middle East, the use of specialty additives such as MCFA, which were previously confined to premium piglet and broiler starter diets, is broadening across the production cycle.
Nutritional Value in Young Animal Diets
MCFA and medium chain triglycerides are absorbed directly into the portal circulation without requiring bile salts or re-esterification, making them an efficient energy source for neonatal and weaned animals whose fat digestion capacity is limited. In swine, they are used in creep feed, pre-starter and starter diets and in milk replacers to support energy intake and intestinal development during the weaning transition, the period most associated with post-weaning diarrhoea. In poultry, they are used in starter feeds and drinking water to support early gut colonisation and to control pathogens such as Clostridium perfringens, the cause of necrotic enteritis. The withdrawal of pharmacological zinc oxide in the European Union from June 2022 increased the attention paid to nutritional strategies for piglet gut health, and MCFA are among the ingredients used in combination programmes that have been adopted to manage the weaning period.
Expansion of Poultry Production in Emerging Markets
Poultry is projected to account for the largest share of growth in global meat production over the next decade, with rapid expansion in South Asia, Southeast Asia, the Middle East and Africa. In these markets, the move to commercial broiler and layer production and the tightening of antibiotic rules, such as India's colistin ban, create demand for gut-health additives. Monolaurin and C8/C10 blends that can be supplied in feed or drinking water are well suited to broiler and layer systems.
Feed Mitigation as a Standard Biosecurity Practice
Feed mitigation remains a developing practice outside North America. As ASF continues to affect Asia and Europe and as importers scrutinise the biosecurity of feed ingredients, there is scope for MCFA-based mitigants to become a standard element of biosecurity programmes for imported soybean meal, vitamins and other ingredients. The consultation launched by the Canadian Food Inspection Agency in August 2026 on a palm kernel medium chain free fatty acid liquid as a feed ingredient for preservative and gut-modifier uses illustrates continued regulatory engagement with these products.
Non-Palm and Fermentation-Derived MCFA
Sustainability requirements of retailers and integrators are increasing scrutiny of palm-derived ingredients. Fermentation-based production of medium and short chain fatty acids from agricultural residues, such as the processes being scaled up in the Netherlands, offers a route to non-palm MCFA with a lower carbon footprint. Combined with certified sustainable palm and coconut supply chains, these sources can support differentiated, premium products and reduce exposure to the lauric oil market.
Feedstock Price Volatility
C8, C10 and C12 acids are derived predominantly from coconut oil and palm kernel oil, and their prices therefore follow the lauric oil market, which is concentrated in Southeast Asia and exposed to weather and policy shocks. According to the International Coconut Community, coconut oil prices rose from approximately USD 1,976 per tonne in January 2025 to a peak of approximately USD 2,742 per tonne in August 2025, driven by dry conditions in the Philippines and Indonesia and firm oleochemical and biofuel demand. C8 and C10 are minor fractions of lauric oils, so their supply depends on the economics of the wider oleochemical chain. Feedstock-driven price increases are difficult to pass on to feed producers, who operate on thin margins and can substitute other acidifiers.
Cost Premium and Competition from Alternative Additives
MCFA products are typically more expensive per tonne of treated feed than conventional organic acid blends, and feed mitigation applications compete with formaldehyde-based products where these are permitted. Feed producers can also choose among butyrates, phytogenics, probiotics, enzymes and zinc-free mineral strategies for gut health. In price-sensitive markets and during periods of low livestock margins, inclusion of MCFA tends to be restricted to high-risk periods or the most valuable animals, limiting volume growth.
Regulatory Classification and Claims
MCFA are classified differently across jurisdictions. In the European Union, octanoic, decanoic and dodecanoic acids are authorised as sensory additives (flavouring compounds) for all animal species under Implementing Regulation (EU) 2017/53, while MCFA glycerides and triglycerides are commonly marketed as feed materials. Neither route permits explicit claims on pathogen reduction or gut flora stabilisation, which require zootechnical additive authorisation. This restricts suppliers' ability to communicate efficacy and increases the cost and time of bringing new claims to market.
Shift to Glycerides and Targeted-Release Forms
Suppliers are moving from free acids towards mono-, di- and triglycerides, salts and encapsulated forms. Glycerides reduce odour and corrosiveness, improve palatability, and can deliver MCFA further along the intestinal tract. Products such as BASF's BalanGut LS, Eastman's Entero-Nova range and Oleon's glycerol monolaurate grades illustrate the trend towards glyceride chemistry, often combined with short chain fatty acid glycerides.
Synergistic Multi-Component Blends
MCFA are increasingly combined with organic acids, butyrates, phenolic compounds and phytogenics to broaden the antimicrobial spectrum and target different sections of the gut. Nutreco's Presan range, which blends MCFA, slow-release C12, butyrates, organic acids and phenolic compounds, is an example. This trend favours suppliers with broad additive portfolios and formulation capabilities.
Drinking Water Applications
Water-soluble MCFA and monoglyceride formulations are being developed for administration through drinking water, enabling targeted use during disease challenges, vaccination or stress periods without changing the feed formulation. Berg + Schmidt's LipoVital WS, presented in 2024, is one such product. Water application is particularly relevant to poultry, where water medication is a common practice.
Demonstrating Return on Investment
A persistent challenge is demonstrating consistent performance and economic returns under field conditions, where results vary with disease pressure, diet and management. Feed producers and integrators increasingly require trial data from their own systems before adopting MCFA products, which lengthens sales cycles and raises the importance of technical service.
The MCFA feed value chain extends from the cultivation of lauric oil crops to the use of MCFA products on livestock farms.
Raw materials and inputs: Coconut oil and palm kernel oil, produced mainly in Indonesia, Malaysia and the Philippines, are the principal feedstocks. These oils are split into fatty acids and fractionated by oleochemical producers to obtain C8, C10 and C12 acids. Glycerol from fat splitting is used for glyceride synthesis, and carriers such as silica are used for dry products. Fermentation of agricultural residues is an emerging alternative source.
Manufacturing: Feed additive companies and oleochemical producers convert the fatty acids into feed-grade products by esterification to mono-, di- and triglycerides, salt formation, blending with other actives, encapsulation and adsorption on carriers. Value is added through proprietary formulations, quality control and the development of efficacy data.
Distribution and channels: Products are sold directly to large feed manufacturers, premixers and integrators, and through specialist distributors in fragmented markets. Technical service, including formulation support and trial management, is an important part of the offering.
End users: Compound feed manufacturers, premix producers, integrated swine and poultry producers, and farms incorporate MCFA into feed, premixes and drinking water for swine, poultry, ruminants, aquaculture and other species.
North America
United States: The Federal Food, Drug, and Cosmetic Act and FDA Center for Veterinary Medicine oversight govern animal food ingredients. The Veterinary Feed Directive final rule (21 CFR Part 558), effective 1 October 2015, together with Guidance for Industry #213 (fully implemented January 2017) and #263 (June 2023), restricts medically important antimicrobials in feed. The FSMA rule on Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals (21 CFR Part 507) applies to feed mills. The memorandum of understanding between FDA and AAFCO on ingredient definitions expired on 1 October 2024, with FDA moving to its own animal food ingredient consultation process.
Canada: Feeds are regulated by the Canadian Food Inspection Agency under the Feeds Act and Feeds Regulations. In August–September 2026, CFIA consulted on the approval of a palm kernel medium chain free fatty acids liquid for use as a preservative and as a component of gut-modifier products for poultry and swine.
Europe
Regulation (EC) No 1831/2003 on additives for use in animal nutrition establishes the authorisation procedure, the five additive categories and the ten-year authorisation period; it ended the use of antibiotics other than coccidiostats and histomonostats as feed additives from 1 January 2006.
Commission Implementing Regulation (EU) 2017/53 authorises octanoic, decanoic and dodecanoic (lauric) acid among other flavouring compounds as sensory additives for all animal species.
Regulation (EU) 2019/4 on medicated feed and Regulation (EU) 2019/6 on veterinary medicinal products, both applicable since 28 January 2022, prohibit the routine and prophylactic use of antimicrobials in feed and restrict metaphylaxis.
Regulation (EU) No 68/2013 on the Catalogue of feed materials and Regulation (EC) No 767/2009 on the placing on the market and use of feed govern the marketing of MCFA products sold as feed materials.
Asia Pacific
China: The Regulations on the Administration of Feed and Feed Additives govern the sector, and MARA Announcement No. 194 (2019) withdrew growth-promoting drug feed additives from 1 January 2020 and required feed mills to stop producing feed containing them from 1 July 2020.
India: The Government of India prohibited the manufacture, sale and distribution of colistin and its formulations for food-producing animals, poultry, aqua farming and animal feed supplements in 2019 under Section 26A of the Drugs and Cosmetics Act, 1940. Bureau of Indian Standards specifications such as IS 1374 (poultry feeds) and IS 2052 (compounded feeds for cattle) set feed quality standards.
Japan: The Act on Safety Assurance and Quality Improvement of Feeds (Act No. 35 of 1953) governs feed and feed additives, with the Ministry of Agriculture, Forestry and Fisheries designating feed additives and FAMIC conducting inspections and assessments.
Latin America
Brazil: The Ministry of Agriculture and Livestock (MAPA) regulates feed additives under Law No. 6,198/1974 and Normative Instruction SARC No. 13 of 2004. Decree No. 12,031 of 2024 updated the rules on the inspection of animal feed products, and Normative Instruction SDA No. 1 of 2020 prohibited tylosin, lincomycin and tiamulin as performance enhancers.
Argentina: Feed products and additives are registered with the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
Saudi Arabia: Feed products are regulated by the Saudi Food and Drug Authority, with the Ministry of Environment, Water and Agriculture responsible for livestock production policy.
South Africa: Farm feeds are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947), administered by the Department of Agriculture.
Gulf Cooperation Council: GCC standardisation bodies issue technical regulations for feed, and national authorities in the UAE and other member states administer feed import and registration requirements.
The table below summarises key developments by the profiled companies since 2022, including product launches, acquisitions, partnerships and expansions.
Jan 2023: Nutreco; Rebranding; US subsidiary Micronutrients was rebranded as Selko, establishing Selko as Nutreco's single global feed additive brand.
Feb 2023: Adisseo; Acquisition; Completed the acquisition of Nor-Feed, a French producer of botanical feed additives, expanding its specialty ingredients portfolio.
Aug 2023: Berg + Schmidt; Expansion; Opened Berg and Schmidt Middle East Trading LLC in Dubai to serve feed additive customers in the Gulf region.
Dec 2023: Oleon; Product launch; Presented its glycerol monolaurate feed portfolio, including Radiamuls MG 2549V and MG 2440V for poultry and swine premixes.
Apr 2024: Berg + Schmidt; Restructuring; Established Animal Nutrition as an independent business with new branding within the Stern-Wywiol Gruppe.
Jul 2024: Nutreco; Acquisition; Agreed to acquire AECI Animal Health in South Africa, strengthening Trouw Nutrition's presence in Africa.
Nov 2024: Berg + Schmidt; Product launch; Presented LipoVital WS, a water-soluble short and medium chain monoglyceride product for drinking water application, at EuroTier 2024.
Mar 2025: Kemin Industries; Product launch; Launched PROSIDIUM, a feed pathogen control solution, at VIV Asia 2025 in Bangkok.
May 2025: Kemin Industries; Acquisition; Acquired Bactana, an intestinal health and fermentation company, to expand its gut-health capabilities.
Jun 2025: Eastman; Partnership; Granted NutriQuest an exclusive license to its Enhanz feed additive for swine and poultry.
Oct 2025: BASF; Strategic review; Announced evaluation of strategic options for its feed enzymes business.
Nov 2025: BASF; Divestment; Signed a binding agreement to sell its global glycinate business to Biochem.
May 2026: Royal Agrifirm Group; Acquisition; Completed the acquisition of Hamlet Protein, integrating it into its Specialties division.
Political
Government action on antimicrobial resistance, including national action plans aligned with the WHO, FAO and WOAH One Health approach, supports non-antibiotic additives.
Trade measures and import restrictions linked to ASF influence pork export flows and the emphasis placed on feed biosecurity.
Agricultural support for livestock self-sufficiency in countries such as Saudi Arabia and India encourages investment in commercial poultry production.
Economic
Livestock production margins and feed costs determine the willingness of producers to pay for specialty additives.
Lauric oil prices drive MCFA production costs, with coconut oil prices rising sharply in 2025.
Rising incomes in emerging economies increase meat consumption and compound feed demand.
Social
Consumer and retailer preferences for meat produced without antibiotics, particularly in the United States and Europe, encourage antibiotic-free production programmes.
Animal welfare expectations favour nutritional strategies that support animal health during weaning and early life.
Urbanisation is shifting protein consumption towards poultry and processed meat.
Technological
Advances in esterification, encapsulation and microencapsulation enable targeted delivery and improved palatability.
Fermentation-based production of medium and short chain fatty acids offers non-palm sources.
Research on pathogen inactivation in feed and on gut microbiome effects strengthens the evidence base for MCFA.
Environmental
Deforestation concerns associated with palm oil increase demand for certified sustainable or non-palm feedstocks.
Climate events such as El Niño affect coconut and palm yields and feedstock supply.
Improved feed efficiency and reduced mortality can lower the environmental footprint per unit of meat produced.
Legal
Feed additive authorisation regimes determine the claims MCFA suppliers can make and the cost of market entry.
Prescription requirements for antimicrobials in the United States and the European Union restrict preventive antibiotic use.
Feed safety laws, such as the FSMA animal food rule and EU feed hygiene rules, increase the focus on feed pathogen control.
Profiles of 30 companies operating in the Medium Chain Fatty Acids Feed Market market, including revenue, employee count, and market positioning where available.
Showing 30 of 30 companies
### Identity and listing | Field | Detail | |---|---| | Entity profiled | Eastman Chemical Company (exact legal-name match; active; publicly listed) | | Listing status vs. input list | Confirmed public company — matches the type supplied | | Former names / predecessors | Tennessee Eastman Company / Corporation (Kodak's chemical subsidiary, founded 1920); Eastman Chemical Products (marketing arm); operated as Eastman Kodak's chemicals division until spin-off | | Founding year | 1920 (Kingsport, Tennessee, by George Eastman) | | Incorporation | Delaware, 1993 (2026 Proxy, "Eastman at a Glance") | | Spin-off from Eastman Kodak | Effective 31 Dec 1993; NYSE trading from early January 1994 | | Headquarters | 200 South Wilcox Drive, Kingsport, Tennessee 37660, USA | | Exchange / ticker | New York Stock Exchange: EMN | | ISIN / CUSIP | US2774321002 / 277432100 (standard identifiers; not re-checked against filing cover page) | | Fiscal year end | 31 December | | Auditor | PricewaterhouseCoopers LLP (ratified for FY2026 at 7 May 2026 AGM; lead partner rotated in 2026) | | Website | www.eastman.com | | Market capitalization | USD 7.39 billion (5 Oct 2026, share price USD 64.62; 114.33 million shares) | | Enterprise value | USD 12.16 billion (S&P Global via StockAnalysis, 5 Oct 2026) | | Credit ratings | Moody's Baa2 (outlook negative, changed ~Aug 2026); S&P BBB (outlook negative since Aug 2025, affirmed Nov 2025); Fitch: BBB historically (current outlook n/v) | | CEO & Board Chair | Mark J. Costa (CEO since January 2014) | | Customers served | More than 100 countries | | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Employees (approx., headcount) | 14000 | 14000 | 13000 | Sources: FY2024 headcount from company boilerplate in August 2025 releases ("approximately 14,000"); FY2025/2026 from FY2025 results release and 2026 Proxy ("approximately 13,000"). The roughly 7% reduction between 2024 and 2025 aligns with corporate severance charges of USD 34 million booked in FY2025 (FY2025 financial tables, Table 3A note 7). Eastman is a ~USD 8.8 billion, Kingsport-headquartered specialty materials producer whose competitive identity rests on deeply integrated, largely U.S.-based asset complexes in Tennessee and Texas that convert coal-derived syngas, cellulose, propane and—increasingly—waste plastic into higher-value polymers, films, additives and fibers. Roughly two-thirds of revenue comes from two specialty segments (Advanced Materials and Additives & Functional Products) anchored by franchise brands such as Saflex interlayers, LLumar window films, Tritan copolyester, Therminol heat-transfer fluids and Naia textiles. The remaining third—Chemical Intermediates and Fibers—supplies scale, integration economics and cash but carries commodity cyclicality and structural decline risk (acetate tow). Management's differentiator is an "innovation-driven growth model" layered with a circular-economy platform (Kingsport methanolysis molecular recycling). The investment debate centres on whether innovation and circularity can outrun cyclical demand, an elevated 3x+ leverage profile, and a decade of flat-to-declining revenue. --- ### Company's own description (paraphrased from FY2025 releases and 2026 Proxy) Eastman describes itself as a global specialty materials company that produces a broad range of products found in everyday items, with a stated purpose of enhancing the quality of life in a material way. It attributes its growth to an innovation-driven model built on world-class technology platforms, deep customer engagement and differentiated application development, which it uses to grow leading positions in attractive end markets—explicitly naming transportation, building and construction, and consumables. The 2026 Proxy adds that its strategy is founded on innovating sustainable solutions and maintaining its social license to operate, framed around a "triple challenge" of carbon neutrality, circularity and caring for society. ### Independent characterization Eastman is best understood as a hybrid specialty/intermediates producer whose specialty franchises sit on top of integrated commodity-like streams. Four integrated technology streams underpin the portfolio: 1. **Acetyl/cellulosics stream (Kingsport):** coal gasification produces syngas → methanol → acetic acid/acetic anhydride; combined with wood pulp to make cellulose esters (cellulose acetate flake, CAB, CAP). Outputs feed acetate tow and textile yarn (Fibers), cellulose-ester coatings additives (AFP), and cellulose-based plastics (AM). 2. **Polyester/copolyester stream (Kingsport):** proprietary monomers (e.g., CHDM, TMCD) enable Tritan and Eastar copolyesters; the methanolysis molecular-recycling unit depolymerizes polyester waste back into monomers that substitute for virgin feedstock. 3. **Olefins/oxo stream (Longview, Texas — second-largest site):** propane/ethane cracking → propylene/ethylene → oxo alcohols, plasticizers, glycol ethers and solvents (Chemical Intermediates), plus feedstock for specialty additives. 4. **Alkylamines and specialty fluids (Taminco/Solutia heritage):** methylamines, ethylamines and higher amines for agriculture, water treatment, personal care and pharma; Therminol heat-transfer fluids and Skydrol aviation hydraulic fluids. ### Revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Product sales (B2B) | ~99%+ | Essentially all revenue is from manufactured-product sales under spot, contract and cost-pass-through arrangements | | Technology licensing | Not separately disclosed (immaterial) | Oxo process technology licensing; APAC licensing programs were discontinued in 4Q2025 (USD 13 million adjustment in CI segment) | | Services / subscription | None material | Technical service is bundled with product sales | Pricing mechanisms (FY2025 releases): AFP uses cost-pass-through contracts for a meaningful share of volume (price +3% in FY2025 explicitly attributed to them); Fibers acetate tow is sold under annual contracts with minimum commitments (2Q2026 call: tow volumes rise in 2H as customers meet annual minimums); CI is spread-driven against propane/ethylene and Asian competition; AM is value-priced (management "defended price" in 4Q2025 despite volume declines). ### Value-chain position Eastman sits in the mid-stream to downstream of the chemical value chain: it is backward-integrated into basic feedstocks (syngas, olefins) but sells primarily to converters and OEM tier suppliers—windshield laminators, film converters/installers, plastic molders, coatings formulators, agrochemical formulators, cigarette-filter makers and textile mills—rather than to consumers. Brand recognition at consumer level exists for a few franchises (LLumar films, Tritan in drinkware, Naia in apparel), which supports co-branding and pricing. ### Customer types and end markets The 2026 Proxy lists FY2025 revenue by end-use market across: Transportation; Building and Construction; Consumables; Durables and Electronics; Personal Care and Wellness; Filter Media; Medical and Pharma; Industrial Chemicals; Food, Feed and Agriculture; Water Treatment and Energy; and Other Markets. The proxy states 56% of revenue arises outside North America (FY2025). Customer concentration: no single customer is disclosed as ≥10% of sales in sources reviewed (n/v).
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
3 interactive charts drawn from the Medium Chain Fatty Acids Feed Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Medium Chain Fatty Acids Feed Market By Livestock
Global Medium Chain Fatty Acids Feed Market By Product Type
Global Medium Chain Fatty Acids Feed Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
